Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : Entities Severed from October Bellwether Trial

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/15/2019 | 04:22pm EDT

WOONSOCKET, R.I., August 15, 2019 - On August 15, 2019, Judge Polster of the United States District Court for the Northern District of Ohio entered an order severing the CVS entities from the main bellwether opioid trial scheduled for October 2019. Judge Polster granted the order to simplify the October trial and make it more manageable. Judge Polster has not set a trial date for the CVS entities and other severed defendants.

Disclaimer

CVS Health Corporation published this content on 15 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 August 2019 20:21:10 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
09/16Opioid plaintiffs fight bid to disqualify U.S. judge before trial
RE
09/16IMPORTANT INVESTOR REMINDER : The Schall Law Firm Announces the Filing of a Clas..
BU
09/13The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CV..
BU
09/13Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CV..
BU
09/12CVS HEALTH : Google Photos and CVS Pharmacy Team Up to Offer Same-Day Printing a..
PR
09/11Surescripts in Dispute With ReMy Health -CNBC
DJ
09/09Walgreens Boots Alliance on Pace for Largest Percent Increase in Over a Year ..
DJ
09/09CVS HEALTH : American College of Rheumatology - Rheumatology Leaders Concerned C..
AQ
09/09AETNA : Voices of Health Competition Kicks Off Today
PR
09/06ALPHABET, MATCH GROUP, CVS : Stocks That Defined The Week
DJ
More news
Financials (USD)
Sales 2019 253 B
EBIT 2019 15 012 M
Net income 2019 6 583 M
Debt 2019 63 327 M
Yield 2019 3,15%
P/E ratio 2019 12,5x
P/E ratio 2020 11,3x
EV / Sales2019 0,58x
EV / Sales2020 0,54x
Capitalization 82 269 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 71,69  $
Last Close Price 63,26  $
Spread / Highest target 45,4%
Spread / Average Target 13,3%
Spread / Lowest Target -8,31%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President